CTRI/2019/01/017054已完成未知
Our initial experience with Atosiban for preterm labour in a tertiary care centre
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients with preterm labour Singleton/ multi fetal gestation beyond 24weeks of gestation to
- •33 weeks + 6 days with intact amniotic membranes
排除标准
- •1. All patients with preterm rupture of membranes
- •2. All patients of abruptio placenta
- •3. All patients less than 24 weeks of gestation
- •4. All patients more than 34 weeks of gestation
- •5. All patients with fever , tachycardia and positive CRP in maternal blood on admission
- •6. All patients with IUD /congenital anomaly
- •7. Patients needing more than one tocolytic agent.
研究者
相似试验
已完成
4 期
Atosiban Versus Placebo in the Treatment of Late Threatened Pre-term BirthPreterm BirthNCT05693688Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)760
进行中（未招募）
1 期
Suppression of contractions versus no suppression of contractions in the treatment of women giving birth too early.eonatal outcome in threatened preterm birth between 30 and 34 weeks of gestation.EUCTR2017-001007-72-NLAmsterdam UMC location AMC760
招募中
3 期
Atosiban versus placebo in the treatment of late threatened preterm birth (APOSTEL VIII).theatened preterm labourthreatened preterm birth10010273NL-OMON54673Academisch Medisch Centrum745
撤回
3 期
Nifedipine Treatment in Preterm LaborThreatened Preterm LaborNCT01314859Hospital Clinico Universitario de Santiago
进行中（未招募）
1 期
ARCADIA: Phase II proof of concept study of Abatacept (Orencia) in individuals who aRe Considered At risk of Developing Inflammatory ArthritisInflammatory arthritisMedDRA version: 20.0Level: PTClassification code 10003246Term: ArthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2015-005285-38-GBThe University of Leeds58